Scientists have identified a potential protective neural pathway in the brain that may slow the progression of Parkinson’s disease—but the effect appears to occur only in women. The findings were published in the Journal of Neuroscience.

The study is based on experimental models examining the function of dopamine-producing neurons—the cells whose degeneration underlies Parkinson’s disease.

The key mechanism involves the activation of receptors sensitive to acetylcholine, a natural neurotransmitter involved in regulating movement and communication between neurons. These receptors also interact with nicotine; however, the researchers used a crucial alternative strategy—enhancing receptor activity without using nicotine.

They found that boosting this signaling pathway helps preserve dopamine neurons and reduces signs of their degeneration. In essence, this points not just to symptom relief but to a potential protective effect on the cells themselves, which could theoretically slow disease progression.

One of the most striking findings was that this protective effect was observed only in female models. No similar benefit was seen in males, suggesting significant biological differences in how neurodegeneration occurs between sexes.

The researchers note that Parkinson’s disease is known to manifest differently in men and women, potentially due to hormonal influences, receptor activity, and cellular regulation.

According to the authors, the goal of the study was not to investigate nicotine itself, but to uncover intrinsic protective mechanisms in the brain. Nicotine merely helped point to a pathway that could be targeted through other means.

Since current treatments are largely focused on managing symptoms rather than halting disease progression, the discovery of such a mechanism could represent an important step toward future therapies aimed at slowing neurodegeneration rather than simply compensating for its effects.